Common immune checkpoint molecules in tumors include PD-L1, PD-1, CTLA4, etc. PD-L1/PD-1 is the most prevalent immune checkpoint, playing a crucial role in regulating the TME and facilitating immune escape [30,31], with its expression predicting the efficacy of tumor immunotherapy [32,33]. The gene discussed is CTLA4; the disease is neoplasm.